Navigation Links
DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
Date:4/21/2013

f the view that success for this facility would come from leveraging both local and global demand. BPA's ongoing partnership with DSM brings a wealth of expertise to the region. Brisbane is home to sophisticated biomanufacturing technology and this contract with DecImmune bolsters the city as an internationally-recognized location for biotherapeutic development." BPA, an industry-development company owned by the Queensland State Government, put together the partnering deal with DSM Biologics, and is currently project managing the final stages of the construction of the new state-of-the-art facility in cooperation with DSM Biologics.

Financial terms were not disclosed.

DecImmune Therapeutics
DecImmune Therapeutics was founded by Michael Carroll Ph.D. (Boston Children's Hospital, Harvard Medical School), and Francis Moore Jr. MD (Brigham and Women's Hospital, Harvard Medical School).  Drs. Moore and Carroll discovered the non-muscle myosin heavy chain II ("N2") cascade that is initiated following vascular injury.  Shortly after expression of the N2 neoepitope on the cell surface in the vasculature, IgM components of the innate immune pathway bind and initiate the cascade responsible for localized tissue damage.  DecImmune is developing an antibody-based therapeutic that can prevent tissue damage and preserve organ function by inhibiting activation of the N2 neoepitope in the innate autoimmune pathway. More information can be found at www.decimmune.com.DSM – Bright Science. Brighter Living .™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM del
'/>"/>

SOURCE DSM Pharmaceutical Products
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Serina Therapeutics Announces Agreement Retaining Woodside Capital Partners as Advisor and Investment Bank
2. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
3. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
4. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
5. Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
6. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
7. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
8. Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA
9. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
10. Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent
11. Halozyme Therapeutics Names Matt Posard to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... MOUNTAIN VIEW, Calif. , July 30, 2015 /PRNewswire/ ... that it will release its second quarter 2015 financial ... 6, 2015.   In conjunction with the release, the ... community at 5:00 p.m. Eastern Time on ... results of the quarter and other business developments. ...
(Date:7/30/2015)... bring you a special edition of #MedicareMonday on Medicare,s 50 th anniversary. As ... resources and continue highlighting the success of the prescription drug benefit, commonly referred to ... our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced ... second quarter ending June 30, 2015. ... We are excited to be near the completion of ... with topline results expected in the fourth quarter," stated ... Inc. "Translarna is now commercially available in 12 countries ...
Breaking Medicine Technology:IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10
... 24 BioTrends Research Group, Inc. recently published its ... report is based on online ... interventional radiologists and interventional nephrologists). It provides an in-depth ... practice patterns related to both vascular access placement and ...
... Mass., Aug. 24 Echo Therapeutics, Inc. (OTC Bulletin ... needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal ... for transdermal drug delivery, today announced the completion of ... designed to evaluate the ability of Prelude to ablate ...
Cached Medicine Technology:Latest BioTrends Report Provides Comprehensive Market Landscape of the Dialysis Vascular Access Market 2Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream 2Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream 3
(Date:8/1/2015)... , ... August 01, 2015 , ... “ reTXT ” ... at the latest and coolest applications on the market for iOS, Android, and Windows. ... shared with viewers allows users to clarify, edit and delete any message including ones ...
(Date:7/31/2015)... ... , ... The Honor Society of Nursing, Sigma Theta Tau International (STTI) convened ... 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders from Central and ... Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources for Health, Department ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... new store run by GoodThreads. The store can be accessed by visiting ... many of which are customizable. The best part: whenever a product is purchased, ...
(Date:7/31/2015)... IL (PRWEB) , ... July 31, 2015 , ... ... to communicate. Rally Insurance Group, Inc. has re-branded their social media profiles to ... a personal way for consumers to communicate, find information, share insights and opinions. ...
(Date:7/31/2015)... ... 31, 2015 , ... According to an article published July 2 ... could reach a consensus on the steps that need to be taken to successfully ... 90 percent consensus on a series of steps that each surgeon must complete for ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... PercuNav System Cart Allows Easier Operation and Improved ... Traxtal Inc., the pioneer and world leader ... a newly designed system cart for the PercuNav ... at Booth # 322 of the Society of ...
... Bioniche Life Sciences Inc. (TSX: BNC), a research-based, ... Company has amended the maturity date of its ... (formerly Laurus Master Funds). , On October 31, ... extension of this facility, originally scheduled to mature ...
... $10 - Plus More Women,s Health MedicationsGRAND RAPIDS, Mich., ... Market, Family Fare and VG,s pharmacies will expand their ... - now there are two programs offering lower prices ... needs and healthcare budgets of our customers. These pharmacies ...
... "Eco Friendly and Green" awards movement, Allstar Awards of Placentia, California, ... is to promote environmentally safe awards as an alternative to the ... ... 2009 -- Striving to be at the forefront of the "Eco ...
... common skin disorders to hepatitis or HIV, is now available in ... peptides induces modulation and regulation of the immune system. GKL03 (Thymrevit) ... , ... Mannheim, Germany -- A new preparation highly beneficial ...
... It,s estimated that more than a half million kids in ... That,s an average of a kid per minute- every minute of ... surprise you to know that almost all of them are treated ... of diagnosing and treating concussions in kids. , 13 ...
Cached Medicine News:Health News:Traxtal to Introduce Next-Generation PercuNav System Cart at SIR Annual Scientific Meeting 2Health News:Bioniche Revolving Credit Facility Maturity Date Amended 2Health News:D&W Fresh Markets, Family Fare and VG's Expand Discounted Generic Drug Program 2Health News:D&W Fresh Markets, Family Fare and VG's Expand Discounted Generic Drug Program 3Health News:D&W Fresh Markets, Family Fare and VG's Expand Discounted Generic Drug Program 4Health News:Allstar Awards Announces its New Ecologically Friendly Product Website 2Health News:Allstar Awards Announces its New Ecologically Friendly Product Website 3Health News:German Medical Advancement Reflects Major Improvement in Individuals with Common and Chronic Illnesses Related to Immune System Dysfunction 2Health News:Classifying concussions could help kids 2Health News:Classifying concussions could help kids 3
... two perforations which enable procedure-specific ... single or bilateral configurations to ... has two perforations which enable ... various single or bilateral configurations ...
Used after ablation to wash away particulate from anterior & posterior sides of flap & stromal bed. Conforms to the corneal flap. .0mm extension with a 11.0mm radius, Angled tip....
Dome shape, extra smooth tip provides safe insertion through wound & manipulation within the eye. 45, 4.0mm from end...
Designed to provide more effective infusion, .90mm(20 G) ultra thinwall cannula with 45 beveled tip allows 30 percent more fluid flow than a regular wall cannula...
Medicine Products: